What is the treatment of bladder cancer?
The treatment of bladder cancer Bacillus calmethe-guerin (BCG) is a form of immunotherapy, which significantly reduces the risk of re-formation of the bladder after surgically removal of cancer. Treatment is ideal for patients who are at the middle or high risk of re -cancer. Historically developed as a vaccine for tuberculosis (TB), BCG is prepared from a living trunk of weakened bacteria, beef tuberculosis bacillus, which has a stimulating effect of the immune system.
since the 1980s. The 20th century showed assembly evidence efficacy of the treatment of BCG bladder cancer as a viable forms of immunotherapy. Although the exact mechanism is unclear, BCG bacteria works by stimulating the immune system in the fight against cancer cells. The synthetic form of a protein of the immune system called interferon, which can help physical combat infections, can be used to treat bladder cancer and sometimes used in combination with BCG.
Treatment of bladder cancer BCG isAintravesically he dministed through the urinary catheter. Treatment is usually given cyclically, once a week for six weeks and for two years every three to six months. The intake of fluids should be limited to four hours before the treatment of bladder cancer treatment. During treatment, urination is forbidden for two hours and some movement may be required to ensure that the entire bladder wall is covered. After treatment, caffeine drinks should be avoided for two hours and the genital area should be washed after each urination for six hours.
The potential side effects of bladder cancer treatment are generally mild. Burning or pain during urination is common. Changes in urination, fatigue, joint pain, fever, loss of appetite and nausea have also been reported. Less common but more serious side effects include hepatitis; abscess; and inflammation of the lung tissue, stew, testicles, nobo skin. Other less common but more serious side effects include bladder contraction, uretera obstruction, allergic reaction, low white blood cells or bloody urine. People who are in the immunosuppressive condition or are pregnant should not be exposed to BCG.
Historically, the most common use of BCG for tuberculosis immunization. The BCG vaccine was first used in people in 1921. Medical professionals recommend administration of BCG children who were born in countries where TB is common. There are several other uses for BCGs, including leprosy treatment, Burili cancer, colorectal cancer, diabetes, chronic problems with inflammatory bladder and multiple sclerosis.